Abstract
Twenty-one adults, highly sensitive to urushiol, the allergen in poison oak/ivy, ingested up to 300 mg of urushiol over three to six months. A control group received placebo capsules. The study was done double blind to evaluate changes in patch test reactivity to urushiol, altered reactivity to an unrelated contract sensitizer, side effects, and duration of hyposensitization. A significant number of subjects in the experimental group (15/21) became hyposensitized. Such hyposensitization was not seen in the control group (2/12), and the difference between groups was significant. No change in reactivity to an unrelated contact sensitizer occurred in subjects hyposensitized to urushiol, suggesting antigen specificity. Retesting up to three months after completion of the protocol indicated that subjects remained hyposensitized without a "rebound" effect during the time. Side effects, detected by questionnaire, were limited to vesicular and urticarial rashes and pruritus ani in 18 of 21 test subjects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
